Cargando…

Hypoxia increases RCC stem cell phenotype via altering the androgen receptor (AR)-lncTCFL5-2-YBX1-SOX2 signaling axis

BACKGROUND: Early studies indicated that the androgen receptor (AR) could promote renal cell carcinoma (RCC) development and metastasis, but its linkage to RCC progression under hypoxia, remains unclear. RESULTS: Here we found AR expression in RCC cells decreased in response to hypoxia, which might...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Changcheng, Sun, Yin, Zhai, Wei, Yao, Xudong, Gong, Dongkui, You, Bosen, Huang, Chi-Ping, Zheng, Junhua, Chang, Chawnshang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670551/ https://www.ncbi.nlm.nih.gov/pubmed/36397101 http://dx.doi.org/10.1186/s13578-022-00912-5

Ejemplares similares

C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion()
por: Yue, Dan, et al.
Publicado: (2017)

AB093. C1QBP regulates YBX1 to suppress the androgen receptor (AR)-enhanced RCC cell invasion
por: Wang, Yong, et al.
Publicado: (2017)

Androgen receptor decreases the renal cell carcinoma bone metastases via suppressing the osteolytic formation through altering a novel circEXOC7 regulatory axis
por: Gong, Dongkui, et al.
Publicado: (2021)

Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status
por: Chen, Yuan, et al.
Publicado: (2015)

Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR
por: You, Bosen, et al.
Publicado: (2021)

Isoform‐specific effects of transcription factor TCFL5 on the pluripotency‐related genes SOX2 and KLF4 in colorectal cancer development
por: Galán‐Martínez, Javier, et al.
Publicado: (2021)

Grammar System of TCFL Driven by Neural Network Technology
por: Xiao, Rui, et al.
Publicado: (2022)

Retracted: Grammar System of TCFL Driven by Neural Network Technology
por: Intelligence and Neuroscience, Computational
Publicado: (2023)

Androgen receptor (AR) pathophysiological roles in androgen-related diseases in skin, bone/muscle, metabolic syndrome and neuron/immune systems: lessons learned from mice lacking AR in specific cells
por: Chang, Chawnshang, et al.
Publicado: (2013)

Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals
por: Deng, Gang, et al.
Publicado: (2021)

Targeting the ERβ/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC
por: Gu, Junfei, et al.
Publicado: (2020)

TCFL5 deficiency impairs the pachytene to diplotene transition during spermatogenesis in the mouse
por: Galán-Martínez, Javier, et al.
Publicado: (2022)

AB106. Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia
por: Zhai, Wei
Publicado: (2016)

High dose androgen suppresses natural killer cytotoxicity of castration-resistant prostate cancer cells via altering AR/circFKBP5/miRNA-513a-5p/PD-L1 signals
por: Tang, Min, et al.
Publicado: (2022)

Targeting inflammatory cytokines-androgen receptor (AR) signaling with ASC-J9(®) to better battle prostate cancer progression
por: Izumi, Kouji, et al.
Publicado: (2013)

Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population
por: Li, Lei, et al.
Publicado: (2015)

The transcription factor TCFL5 responds to A-MYB to elaborate the male meiotic program in mice
por: Cecchini, Katharine, et al.
Publicado: (2023)

Correction: Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population
por: Li, Lei, et al.
Publicado: (2016)

A-MYB/TCFL5 regulatory architecture ensures the production of pachytene piRNAs in placental mammals
por: Yu, Tiangxiong, et al.
Publicado: (2023)

Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progression
por: Chou, Fu-Ju, et al.
Publicado: (2019)

Infiltrating neutrophils increase bladder cancer cell invasion via modulation of androgen receptor (AR)/MMP13 signals
por: Lin, ChangYi, et al.
Publicado: (2015)

Targeting the TR4 nuclear receptor-mediated lncTASR/AXL signaling with tretinoin increases the sunitinib sensitivity to better suppress the RCC progression
por: Shi, Hangchuan, et al.
Publicado: (2019)

Sex, androgens and regulation of pulmonary AR, TMPRSS2 and ACE2
por: Baratchian, Mehdi, et al.
Publicado: (2020)

The lncRNA lincNMR regulates nucleotide metabolism via a YBX1 - RRM2 axis in cancer
por: Gandhi, Minakshi, et al.
Publicado: (2020)

Racial Differences in Androgen Receptor (AR) and AR Splice Variants (AR-SVs) Expression in Treatment-Naïve Androgen-Dependent Prostate Cancer
por: Khan, Farhan, et al.
Publicado: (2023)

Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT → NF-κB → CXCL5 signaling
por: Guan, Zhenfeng, et al.
Publicado: (2016)

circRNA TCFL5 Promote Esophageal Cancer Progression by Modulating M2 Macrophage Polarization via the miR-543-FMNL2 Axis
por: Lin, Chengbin, et al.
Publicado: (2022)

Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals
por: Ou, Zhenyu, et al.
Publicado: (2015)

Phosphorylated YBX2 is stabilized to promote glycolysis in brown adipocytes
por: Zhao, Qingwen, et al.
Publicado: (2023)

Diverse roles of androgen receptor (AR) domains in AR-mediated signaling
por: Claessens, Frank, et al.
Publicado: (2008)

Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
por: Narayanan, Ramesh
Publicado: (2020)

Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2/circ_0001005/PD-L1 signaling
por: Liu, Qing, et al.
Publicado: (2022)

Ars2 maintains neural stem cell identity via direct transcriptional activation of Sox2
por: Andreu-Agullo, Celia, et al.
Publicado: (2011)

Suppressing BCL-XL increased the high dose androgens therapeutic effect to better induce the Enzalutamide-resistant prostate cancer autophagic cell death
por: Xiang, Zhendong, et al.
Publicado: (2021)

ASC-J9® increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-κB survival signals
por: Huang, Chi-Ping, et al.
Publicado: (2019)

LncRNA BASP1‐AS1 interacts with YBX1 to regulate Notch transcription and drives the malignancy of melanoma
por: Li, YaLing, et al.
Publicado: (2021)

Identification of an AR Mutation-Negative Class of Androgen Insensitivity by Determining Endogenous AR Activity
por: Hornig, N. C., et al.
Publicado: (2016)

Androgen receptor regulates ASS1P3/miR-34a-5p/ASS1 signaling to promote renal cell carcinoma cell growth
por: Wang, Kefeng, et al.
Publicado: (2019)

CCAR1 promotes chromatin loading of androgen receptor (AR) transcription complex by stabilizing the association between AR and GATA2
por: Seo, Woo-Young, et al.
Publicado: (2013)

High-dose-androgen-induced autophagic cell death to suppress the Enzalutamide-resistant prostate cancer growth via altering the circRNA-BCL2/miRNA-198/AMBRA1 signaling
por: Chen, Lei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fq72i8p6mgd1v7v4dvcgehuvd8